57.114 Urinary Tract Infection (UTI)

The National Healthcare Safety Network (NHSN)

57.114_UTI_BLANK

57.114 Urinary Tract Infection (UTI)

OMB: 0920-0666

Document [docx]
Download: docx | pdf


OMB No. 0920-0666

Exp. Date: xx/xx/20xx

www.cdc.gov/nhsn

Urinary Tract infection (UTI)

Page 1 of 4

*required for saving **required for completion

Facility ID:

Event #:

*Patient ID:

Social Security #:

Secondary ID:

Medicare #:

Patient Name, Last:

First:

Middle:

*Gender: F M Other

*Date of Birth:

Ethnicity (Specify):

Race (Specify):

*Event Type: UTI

*Date of Event:

Post-procedure UTI: Yes No

Date of Procedure:

NHSN Procedure Code:

ICD-9-CM Procedure Code:

*MDRO Infection Surveillance:

Yes, this infection’s pathogen & location are in-plan for Infection Surveillance in the MDRO/CDI Module

No, this infection’s pathogen & location are not in-plan for Infection Surveillance in the MDRO/CDI Module

*Date Admitted to Facility:

*Location:

Risk Factors

*Urinary Catheter status at time of specimen collection or onset of signs or symptoms:

In place

Removed within 2 calendar days prior

Not in place nor within 2 calendar days prior

Location of Device Insertion: ________________________

Date of Device Insertion: ____ /____ /_______

If NICU, birth weight (gms): ____________


Event Details

*Specific Event:

Symptomatic UTI (SUTI)

Asymptomatic Bacteremic UTI (ABUTI)

Other UTI (OUTI)

*Specify Criteria Used: (check all that apply)

Signs & Symptoms

Laboratory & Diagnostic Testing

Any Patient

1 year old


Fever

Fever

1 positive culture with ≥ 105 CFU/ml with no more than 2 species of microorganisms

Urgency

Hypothermia

Frequency

Apnea

Positive dipstick for leukocyte esterase or nitrite

Dysuria

Bradycardia

Pyuria

Suprapubic tenderness

Dysuria

Microorganisms seen on Gram stain of unspun urine

Costovertebral angle pain or tenderness

Lethargy

1 positive culture with ≥ 103 CFU/ml and < 105 CFU/ml with no more than 2 species of microorganisms

Abscess

Vomiting

Positive culture

Pain or tenderness


Positive blood culture

Purulent drainage or material


Radiographic evidence of infection

Other evidence of infection found on direct exam, during surgery, or by diagnostic tests

per specific site criteria

*Secondary Bloodstream Infection: Yes No

**Died: Yes No

UTI Contributed to Death: Yes No

Discharge Date:

*Pathogens Identified: Yes No *If Yes, specify on pages 2-4.

Assurance of Confidentiality: The voluntarily provided information obtained in this surveillance system that would permit identification of any individual or institution is collected with a guarantee that it will be held in strict confidence, will be used only for the purposes stated, and will not otherwise be disclosed or released without the consent of the individual, or the institution in accordance with Sections 304, 306 and 308(d) of the Public Health Service Act (42 USC 242b, 242k, and 242m(d)).


Public reporting burden of this collection of information is estimated to average 32 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to a collection of information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to CDC, Reports Clearance Officer, 1600 Clifton Rd., MS D-74, Atlanta, GA 30333, ATTN: PRA (0920-0666).

CDC 57.114 (Front) Rev 7, v7.2

Urinary Tract infection (UTI)

Page 2 of 4

Pathogen #

Gram-positive Organisms


_______


Staphylococcus coagulase-negative


VANC

S I R N

(specify): ________________________


_______


Enterococcus spp.( specify):


AMP

S I R N


CIPRO/LEVO/MOXI

S I R N


DAPTO

S NS N


DOXY/MINO

S I R N


GENTHL§

S R N


LNZ

S I R N

___________


STREPHL§

S R N



TETRA

S I R N



TIG

S NS N



VANC

S I R N



_______



Enterococcus faecium


AMP

S I R N


CIPRO/LEVO/MOXI

S I R N


DAPTO

S NS N


DOXY/MINO

S I R N


GENTHL§

S R N


LNZ

S I R N


QUIDAL

S I R N



STREPHL§

S R N



TETRA

S I R N



TIG

S NS N



VANC

S I R N



_______


Staphylococcus aureus


CHLOR

S I R N


CIPRO/LEVO/MOXI

S I R N


CLIND

S I R N


DAPTO

S NS N


DOXY/MINO

S I R N


ERYTH

S I R N


GENT

S I R N



LNZ

S R N



OX/CEFOX/METH

S I R N


QUIDAL

S I R N


RIF

S I R N


TETRA

S I R N


TIG

S NS N


TMZ

S I R N


VANC

S I R N

Pathogen #

Gram-negative Organisms


_______


Acinetobacter spp. (specify):


AMK

S I R N


AMPSUL

S I R N


AZT

S I R N


CEFEP

S I R N


CEFTAZ

S I R N


CIPRO/LEVO

S I R N


COL/PB

S I R N

____________


GENT

S I R N


IMI

S I R N



MERO/DORI

S I R N


PIP/PIPTAZ

S I R N


TETRA/DOXY/MINO

S I R N




TMZ

S I R N


TOBRA

S I R N



_______


Escherichia coli


AMK

S I R N


AMP

S I R N


AMPSUL/AMXCLV

S I R N


AZT

S I R N


CEFAZ

S I R N


CEFEP

S I R N


CEFOT/CEFTRX

S I R N



CEFTAZ

S I R N


CEFUR

S I R N


CEFOX/CETET

S I R N


CHLOR

S I R N


CIPRO/LEVO/MOXI

S I R N


COL/PB

S I R N



ERTA

S I R N


GENT

S I R N


IMI

S I R N


MERO/DORI

S I R N


PIPTAZ

S I R N


TETRA/DOXY/MINO

S I R N




TIG

S I R N


TMZ

S I R N


TOBRA

S I R N



_______


Enterobacter spp. (specify):


AMK

S I R N


AMP

S I R N


AMPSUL/AMXCLV

S I R N


AZT

S I R N


CEFAZ

S I R N


CEFEP

S I R N


CEFOT/CEFTRX

S I R N

____________


CEFTAZ

S I R N


CEFUR

S I R N


CEFOX/CETET

S I R N


CHLOR

S I R N


CIPRO/LEVO/MOXI

S I R N


COL/PB

S I R N



ERTA

S I R N


GENT

S I R N


IMI

S I R N


MERO/DORI

S I R N


PIPTAZ

S I R N


TETRA/DOXY/MINO

S I R N




TIG

S I R N


TMZ

S I R N


TOBRA

S I R N



_______


Klebsiella spp. (specify):


AMK

S I R N


AMP

S I R N


AMPSUL/AMXCLV

S I R N


AZT

S I R N


CEFAZ

S I R N


CEFEP

S I R N


CEFOT/CEFTRX

S I R N

____________


CEFTAZ

S I R N


CEFUR

S I R N


CEFOX/CETET

S I R N


CHLOR

S I R N


CIPRO/LEVO/MOXI

S I R N


COL/PB

S I R N



ERTA

S I R N


GENT

S I R N


IMI

S I R N


MERO/DORI

S I R N


PIPTAZ

S I R N


TETRA/DOXY/MINO

S I R N



TIG

S I R N


TMZ

S I R N


TOBRA

S I R N


Urinary Tract infection (UTI)

Page 3 of 4

Pathogen #

Gram-negative Organisms (continued)


_______


Serratia marcescens


AMK

S I R N


AMP

S I R N


AMPSUL/AMXCLV

S I R N


AZT

S I R N


CEFAZ

S I R N


CEFEP

S I R N


CEFOT/CEFTRX

S I R N



CEFTAZ

S I R N


CEFUR

S I R N


CEFOX/CETET

S I R N


CHLOR

S I R N


CIPRO/LEVO/MOXI

S I R N


COL/PB

S I R N



ERTA

S I R N


GENT

S I R N


IMI

S I R N


MERO/DORI

S I R N


PIPTAZ

S I R N


TETRA/DOXY/MINO

S I R N




TIG

S I R N


TMZ

S I R N


TOBRA

S I R N



_______


Pseudomonas aeruginosa


AMK

S I R N


AZT

S I R N


CEFEP

S I R N


CEFTAZ

S I R N


CIPRO/LEVO

S I R N


COL/PB

S I R N


GENT

S I R N



IMI

S I R N



MERO/DORI

S I R N


PIP/PIPTAZ

S I R N


TOBRA

S I R N


_______


Stenotrophomonas maltophilia


LEVO

S I R N


TETRA/MINO

S I R N


TICLAV

S I R N


TMZ

S I R N

Pathogen #

Fungal Organisms

_______

Candida spp. (specify): ____________


ANID

S I R N

CASPO

S NS N

FLUCO

S S-DD R N

FLUCY

S I R N

ITRA

S S-DD R N

MICA

S NS N

VORI

S S-DD R N

Pathogen #

Other Organisms

_______

Organism 1 (specify)

____________


_______Drug 1

S I R N

_______ Drug 2

S I R N

______

Drug 3

S I R N

_______ Drug 4

S I R N

_______Drug 5

S I R N

______ Drug 6

S I R N

______ Drug 7

S I R N

______ Drug 8

S I R N

______ Drug 9

S I R N

_______

Organism 1 (specify)

____________


_______Drug 1

S I R N

_______ Drug 2

S I R N

______

Drug 3

S I R N

_______ Drug 4

S I R N

_______Drug 5

S I R N

______ Drug 6

S I R N

______ Drug 7

S I R N

______ Drug 8

S I R N

______ Drug 9

S I R N

_______

Organism 1 (specify)

____________


_______Drug 1

S I R N

_______ Drug 2

S I R N

______

Drug 3

S I R N

_______ Drug 4

S I R N

_______Drug 5

S I R N

______ Drug 6

S I R N

______ Drug 7

S I R N

______ Drug 8

S I R N

______ Drug 9

S I R N



Result Codes

S = Susceptible I = Intermediate R = Resistant NS = Non-susceptible S-DD = Susceptible-dose dependent N = Not tested

§ GENTHL and STREPHL results: S = Susceptible/Synergistic and R = Resistant/Not Synergistic

Drug Codes:





AMK = amikacin

CEFTRX = ceftriaxone

ERYTH = erythromycin

MICA = micafungin

STREPHL = streptomycin –

high level test

AMP = ampicillin

CEFUR= cefuroxime

FLUCO = fluconazole

MINO = minocycline

TETRA = tetracycline

AMPSUL = ampicillin/sulbactam

CETET= cefotetan

FLUCY = flucytosine

MOXI = moxifloxacin

TICLAV = ticarcillin/clavulanic acid

AMXCLV = amoxicillin/clavulanic acid

CHLOR= chloramphenicol

GENT = gentamicin

OX = oxacillin

TIG = tigecycline

ANID = anidulafungin

CIPRO = ciprofloxacin

GENTHL = gentamicin –high level test

PB = polymyxin B

TMZ = trimethoprim/sulfamethoxazole

AZT = aztreonam

CLIND = clindamycin

IMI = imipenem

PIP = piperacillin

TOBRA = tobramycin

CASPO = caspofungin

COL = colistin

ITRA = itraconazole

PIPTAZ = piperacillin/tazobactam

VANC = vancomycin

CEFAZ= cefazolin

DAPTO = daptomycin

LEVO = levofloxacin

QUIDAL = quinupristin/dalfopristin

VORI = voriconazole

CEFEP = cefepime

DORI = doripenem

LNZ = linezolid

RIF = rifampin


CEFOT = cefotaxime

DOXY = doxycycline

MERO = meropenem



CEFOX= cefoxitin

ERTA = ertapenem

METH = methicillin



CEFTAZ = ceftazidime





Urinary Tract infection (UTI)

Page 4 of 4

Custom Fields

Label

Label

________________________

____/____/____

_______________________

____/____/_____

________________________

_____________

_______________________

______________

________________________

_____________

_______________________

______________

________________________

_____________

_______________________

______________

________________________

_____________

_______________________

______________

________________________

_____________

_______________________

______________

________________________

_____________

_______________________

______________


Comments


















































File Typeapplication/vnd.openxmlformats-officedocument.wordprocessingml.document
AuthorAmy Schneider
File Modified0000-00-00
File Created2021-01-30

© 2024 OMB.report | Privacy Policy